NJ State Employees Deferred Compensation Plan’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-2,000
Closed -$322K 520
2018
Q1
$322K Buy
+2,000
New +$322K 0.06% 401